Mark Landers

Mark Landers currently serves as the Senior Vice President of Biopharma Partnerships at SAGA Diagnostics since August 2025. Prior to this role, Mark was the Vice President of Precision Medicine at Akoya Biosciences, Inc. from March 2023 to August 2025, and held the position of Vice President of BioPharma Business Development at Exact Sciences from February 2021 to March 2023. Mark has also contributed to Guardant Health as VP of BioPharma Business Development (West) from September 2019 to February 2021, and as Vice President of Translational Research (BioPharma Services) at Epic Sciences from August 2014 to July 2019. Earlier experience includes roles at AltheaDx, Life Technologies, Invitrogen, Ceregene, and PurePulse Technologies, encompassing leadership and scientific positions. Mark earned a degree from San Diego State University between 1990 and 1995.